Colossal Biosciences pioneers de-extinction and advanced genome engineering to address the projected 50% loss of global biodiversity over the next 25 years. By integrating AI with synthetic biology, the company develops "civilization tech"—scalable solutions for invasive species control, human healthcare, and ecological restoration. Operating with a "Harvard meets MTV" philosophy, the organization prioritizes public inspiration alongside scientific rigor, utilizing custom-built hardware and vertical integration to accelerate research. Beyond the high-profile goal of reviving extinct species like the woolly mammoth, the company applies its proprietary gene-editing pipeline to solve urgent problems, such as eradicating disease-carrying pests and developing cancer-resistant therapies based on evolutionary trends in elephants. This systems-based approach transforms traditional conservation by providing a robust, technology-driven toolkit for planetary-scale biological management.
Sign in to continue reading, translating and more.
Open full episode in Podwise